Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-1,141
Closed -$410K 294
2021
Q4
$410K Sell
1,141
-614
-35% -$207K 0.13% 242
2021
Q3
$571K Sell
1,755
-475
-21% -$161K 0.19% 223
2021
Q2
$696K Sell
2,230
-185
-8% -$56.8K 0.2% 203
2021
Q1
$770K Buy
2,415
+1,296
+116% +$415K 0.22% 205
2020
Q4
$363K Buy
+1,119
New +$310K 0.11% 229

Other funds holding ABMD

Fort LP's ABMD Position: Q1 2022 in Review

Fort LP sold out of Abiomed Inc (ABMD) in Q1 2022, closing a stake of 1,141 shares — an estimated $410K sold.

Fort LP first reported a position in ABMD in Q4 2020 and held it in 5 quarters. The position peaked at $770K in Q1 2021. 500 funds tracked by Wall St. Rank hold ABMD as of Q1 2022.

  • Fort LP reported no remaining Abiomed Inc position as of Q1 2022 after selling out during the quarter.
  • Fort LP sold 1,141 Abiomed Inc shares in Q1 2022, an estimated $410K.
  • Fort LP first reported a position in Abiomed Inc in Q4 2020 and held it in 5 quarters.
  • Fort LP's Abiomed Inc position peaked at $770K in Q1 2021.
  • 500 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2022.

Based on Fort LP's 13F filing for Q1 2022, filed 13 May 2022.